1. Vege DS, Soman CS, Joshi UA, Ganesh B, Yadav JN. Undifferentiated tumors: an immunohistochemical analysis on biopsies. J Surg Oncol. 1994;57:273-6. [DOI via Crossref] |
|
2. Bahrami A, Truong LD, Ro JY. Undifferentiated tumor: true identity by immunohistology. Arch Pathol Lab Med. 2008;132:326-48. |
|
3. Henzen-Logmans SC, Mullink H, Vennegoor C, Hilgers J, Oort J, Meijer CJ. Classification of routinely processed anaplastic large cell tumours with a small panel of antibodies. An immunohistochemical study with clinical follow-up. Histol Histopathl. 1987;2:107-18. |
|
4. Ahmed Z, Azad NS, Bhurgari Y, Ahmed R, Kayani N, Pervez S et al. Significance of immunohistochemistry in accurate characterization of malignant tumors. J Ayub Med Coll Abbottabad. 2006;18:38-43. |
|
5. Bianchini WA, Altemani AM, Paschoal JR. Undifferentiated head and neck tumors: the contribution of immunohistochemical technique to differential diagnosis. Sao Paulo Med J. 2003;121:244-7. [DOI via Crossref] |
|
6. Taylor CR, Shi SR, Barr NJ, Wu N. Techniques of immunohistochemistry: principles, pitfalls and standardization. In: Dabbs DJ, editor. Diagnostic Immunohistochemistry, 2nd ed. Philadelphia: Churchill Livingstone Elsevier Inc.; 2006. p. 1-42. [DOI via Crossref] |
|
7. Williams JH, Mepham BL, Wright DH. Tissue preparation for immunocytochemistry. J Clin Pathol. 1997;50:422-8. [DOI via Crossref] |
|
8. Lambhekar NA, Chaturvedi AC, Madur BP. Immunohistochemistry in surgical pathology practice: A current perspective of a simple, powerful, yet complex, tool. Indian J Pathol Microbiol. 2008;51:2-11. [DOI via Crossref] |
|
9. Pity IS. Histopathological and immunohistochemical approach for characterization of undifferentiated malignant tumors. JABHS. 2011;12:49-57. |
|
10. Gatter KC, Alcock C, Heryet A, Pulford KA, Heyderman E, Taylor- Papadimitriou J et al. The differential diagnosis of routinely processed anaplastic tumors using monoclonal antibodies. Am J Clin Pathol. 1984;82:33-43. |
|
11. Gatter KC, Alcock C, Heryet A, Mason DY. Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet. 1985;1:1302-5. [DOI via Crossref] |
|
12. Coindre JM, Tanguy F, Merlio JP, De Mascarel I, De Mascarel A, Trojani M. The value of immunohistological techniques in undifferentiated cancers. Tumori. 1986;72;539-44. |
|
13. Leong AS, Wright J. The contribution of immunohistochemical staining in tumour diagnosis. Histopathology. 1987;11:1295-305. [DOI via Crossref] |
|
14. Van der Gaast A, Verwij J, Planting AS, Stoter G, Henzen-Logmans SC. The value of immunohistochemistry in patients with poorly differentiated adenocarcinomas and undifferentiated carcinomas of unknown primary. J Cancer Res Clin Oncol. 1996;122:181-85. [DOI via Crossref] |
|
15. Rao IS. Role of immunochemistry in lymphoma. Indian J Med Paediatr Oncol. 2010;31:145-7. [DOI via Crossref] |
|
16. Abramson JS, Shipp MA. Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach. Blood. 2005;106:1164-74. [DOI via Crossref] |
|
17. Wick MR. Immunohistochemical approaches to the diagnosis of undifferentiated malignant tumors. Ann Diagn Pathol. 2008;12:72-84. [DOI via Crossref] |
|
18. Georgescu CV, Florescu M, Simionescu C. Value of immunohistochemistry in confirming undifferentiated ovarian carcinomas. Rom J Morphol Embryol. 1999-2004;45:133-42. |
|
19. Machen SK, Fisher C, Gautam RS, Tubbs RR, Goldblum JR. Utility of cytokeratin subsets for distinguishing poorly differentiated synovial sarcoma from peripheral primitive neuroectodermal tumour. Histopathology. 1998;33:501-7. [DOI via Crossref] |
|
20. Bashyal R, Pathak TB, Shrestha S, Pun CB, Banstola S, Neupane S et al. Role of immunohistochemistry in the diagnosis of malignant small round cell tumors. JPN. 2011;1:87-91. |
|
21. Mentzel T, Pedeutour F. Pleomorphic liposarcoma. In: Fletcher C.D.M., Unni K.K., Mertens F, editors: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2002. p. 44-45. |
|
22. Sheffield MV, Yee H, Dorvault CC, Weilbaecher KN, Eltoum IA, Siegal GP et al. Comparison of Five Antibodies as markers in the diagnosis of melanoma in cytologic preparations. Am J Clin Pathol. 2002;118:930-6. [DOI via Crossref] |
|
23. Dehner LP, Tazelaar HD, manabe T. Pleuropulmonary blastoma. In: Travis WD, Brambilla E, Muller- Hermelink HK, Harris CC, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2004. p. 99-100. |
|